1. Home
  2. ITGR vs BLCO Comparison

ITGR vs BLCO Comparison

Compare ITGR & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITGR
  • BLCO
  • Stock Information
  • Founded
  • ITGR 1970
  • BLCO 1853
  • Country
  • ITGR United States
  • BLCO Canada
  • Employees
  • ITGR N/A
  • BLCO N/A
  • Industry
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BLCO Ophthalmic Goods
  • Sector
  • ITGR Health Care
  • BLCO Health Care
  • Exchange
  • ITGR Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • ITGR 4.1B
  • BLCO 4.0B
  • IPO Year
  • ITGR 2000
  • BLCO 2022
  • Fundamental
  • Price
  • ITGR $123.41
  • BLCO $13.73
  • Analyst Decision
  • ITGR Strong Buy
  • BLCO Hold
  • Analyst Count
  • ITGR 10
  • BLCO 12
  • Target Price
  • ITGR $145.40
  • BLCO $18.64
  • AVG Volume (30 Days)
  • ITGR 761.2K
  • BLCO 873.2K
  • Earning Date
  • ITGR 04-24-2025
  • BLCO 04-30-2025
  • Dividend Yield
  • ITGR N/A
  • BLCO N/A
  • EPS Growth
  • ITGR N/A
  • BLCO N/A
  • EPS
  • ITGR 2.18
  • BLCO N/A
  • Revenue
  • ITGR $1,746,192,000.00
  • BLCO $4,791,000,000.00
  • Revenue This Year
  • ITGR $10.86
  • BLCO $6.30
  • Revenue Next Year
  • ITGR $7.15
  • BLCO $5.56
  • P/E Ratio
  • ITGR $56.21
  • BLCO N/A
  • Revenue Growth
  • ITGR 6.95
  • BLCO 15.56
  • 52 Week Low
  • ITGR $104.93
  • BLCO $10.46
  • 52 Week High
  • ITGR $146.36
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • ITGR 58.74
  • BLCO 53.31
  • Support Level
  • ITGR $114.86
  • BLCO $11.62
  • Resistance Level
  • ITGR $126.00
  • BLCO $13.92
  • Average True Range (ATR)
  • ITGR 5.64
  • BLCO 0.80
  • MACD
  • ITGR 1.26
  • BLCO 0.31
  • Stochastic Oscillator
  • ITGR 87.71
  • BLCO 94.51

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: